FR2133752A1 - - Google Patents

Info

Publication number
FR2133752A1
FR2133752A1 FR7213215A FR7213215A FR2133752A1 FR 2133752 A1 FR2133752 A1 FR 2133752A1 FR 7213215 A FR7213215 A FR 7213215A FR 7213215 A FR7213215 A FR 7213215A FR 2133752 A1 FR2133752 A1 FR 2133752A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7213215A
Other languages
French (fr)
Other versions
FR2133752B1 (en:Method
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wellcome Foundation Ltd
Original Assignee
Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Foundation Ltd filed Critical Wellcome Foundation Ltd
Publication of FR2133752A1 publication Critical patent/FR2133752A1/fr
Application granted granted Critical
Publication of FR2133752B1 publication Critical patent/FR2133752B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/41—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by hydrogenolysis or reduction of carboxylic groups or functional derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48—Two nitrogen atoms
    • C07D239/49—Two nitrogen atoms with an aralkyl radical, or substituted aralkyl radical, attached in position 5, e.g. trimethoprim

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
FR7213215A 1971-04-16 1972-04-14 Expired FR2133752B1 (en:Method)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB963971A GB1407971A (en) 1971-04-16 1971-04-16 2,4-diamino -4-3,4,5-triethoxybenzyl pyrimidine and methods of preparation therefor

Publications (2)

Publication Number Publication Date
FR2133752A1 true FR2133752A1 (en:Method) 1972-12-01
FR2133752B1 FR2133752B1 (en:Method) 1975-04-25

Family

ID=9875880

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7213215A Expired FR2133752B1 (en:Method) 1971-04-16 1972-04-14

Country Status (13)

Country Link
JP (3) JPS5320511B1 (en:Method)
AU (1) AU468447B2 (en:Method)
BE (1) BE782153A (en:Method)
CA (1) CA967964A (en:Method)
CH (1) CH565160A5 (en:Method)
CS (1) CS181221B2 (en:Method)
DE (1) DE2218220A1 (en:Method)
DK (1) DK131466B (en:Method)
FR (1) FR2133752B1 (en:Method)
GB (1) GB1407971A (en:Method)
IL (3) IL47921A (en:Method)
NL (1) NL7205043A (en:Method)
SE (1) SE391180B (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2211463A1 (en:Method) * 1972-12-21 1974-07-19 Hoffmann La Roche

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1469521A (en) * 1973-01-05 1977-04-06 Wellcome Found Antimicrobial preparations
FR2502152A1 (fr) * 1981-03-20 1982-09-24 Panmedica Laboratoires Nouveaux derives solubles n2 substitues de la diamino-2,4-benzyl-5-pyrimidines, leur procede de preparation et medicaments les contenant

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (fr) * 1953-03-11 1955-03-30 Wellcome Found Dérivés de pyrimidine et leur fabrication
FR1459417A (fr) * 1964-11-12 1966-04-29 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
FR1518635A (fr) * 1965-07-08 1968-03-29 Wellcome Found Procédé de préparation de dérivés de la pyrimidine
DE2010166A1 (de) * 1969-03-06 1970-09-17 The Wellcome Foundation Ltd., London Stabilisierte alpha-Benzylaerylnitrile, Verfahren zu ihrer Herstellung und ihre Verwendung

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1090394A (fr) * 1953-03-11 1955-03-30 Wellcome Found Dérivés de pyrimidine et leur fabrication
FR1459417A (fr) * 1964-11-12 1966-04-29 Hoffmann La Roche Procédé pour la préparation de dérivés de pyrimidine
FR1518635A (fr) * 1965-07-08 1968-03-29 Wellcome Found Procédé de préparation de dérivés de la pyrimidine
DE2010166A1 (de) * 1969-03-06 1970-09-17 The Wellcome Foundation Ltd., London Stabilisierte alpha-Benzylaerylnitrile, Verfahren zu ihrer Herstellung und ihre Verwendung

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2211463A1 (en:Method) * 1972-12-21 1974-07-19 Hoffmann La Roche

Also Published As

Publication number Publication date
BE782153A (fr) 1972-10-16
AU4117472A (en) 1973-10-18
CA967964A (en) 1975-05-20
IL47921A0 (en) 1975-11-25
AU468447B2 (en) 1976-01-15
JPS5430189A (en) 1979-03-06
GB1407971A (en) 1975-10-01
IL39218A (en) 1976-10-31
NL7205043A (en:Method) 1972-10-18
IL39218A0 (en) 1972-06-28
SE391180B (sv) 1977-02-07
DK131466B (da) 1975-07-21
JPS5422994B2 (en:Method) 1979-08-10
FR2133752B1 (en:Method) 1975-04-25
IL47921A (en) 1976-10-31
DE2218220A1 (de) 1972-11-02
CH565160A5 (en:Method) 1975-08-15
CS181221B2 (en) 1978-03-31
JPS5320511B1 (en:Method) 1978-06-27
DK131466C (en:Method) 1975-12-08
JPS53111083A (en) 1978-09-28

Similar Documents

Publication Publication Date Title
FR2142634A2 (en:Method)
DK131466C (en:Method)
AU2669471A (en:Method)
CS148663B1 (en:Method)
BG17369A1 (en:Method)
CH566715A5 (en:Method)
BG16875A1 (en:Method)
CH606168A5 (en:Method)
CH580662A5 (en:Method)
CH582179A5 (en:Method)
CH544672A4 (en:Method)
CH565484A5 (en:Method)
CH586672A5 (en:Method)
BG17257A1 (en:Method)
CH765671A4 (en:Method)
CH1613472A4 (en:Method)
CH572048A5 (en:Method)
BE782209R (en:Method)
CH591427A5 (en:Method)
CH571705A5 (en:Method)
CH571063A5 (en:Method)
BG19841A1 (en:Method)
BG16894A1 (en:Method)
CH580585A5 (en:Method)
CH580602A5 (en:Method)

Legal Events

Date Code Title Description
ST Notification of lapse